Antagonists: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='4dkl' size='400' side='right' caption='Crystal structure of the mu-opioid receptor bound to a morphinan antagonist, cholesterol, PEG 400, sulfate, mono-oleoyl-glycerol and Cl- ion (PDB entry [[4dkl]])' scene=4dkl/Overall_structure/1''> | <StructureSection load='4dkl' size='400' side='right' caption='Crystal structure of the mu-opioid receptor bound to a morphinan antagonist, cholesterol, PEG 400, sulfate, mono-oleoyl-glycerol and Cl- ion (PDB entry [[4dkl]])' scene=4dkl/Overall_structure/1''> | ||
'''Under construction''' | '''Under construction''' | ||
See also [[Types of ligands]] and [[Signal transduction]]. | |||
Ligands that bind to a receptor but fail to activate the physiological response are receptor '''antagonists'''. | Ligands that bind to a receptor but fail to activate the physiological response are receptor '''antagonists'''. | ||